E.A.P. Croydon

522 total citations
12 papers, 399 citations indexed

About

E.A.P. Croydon is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, E.A.P. Croydon has authored 12 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in E.A.P. Croydon's work include Antimicrobial Resistance in Staphylococcus (5 papers), Drug-Induced Adverse Reactions (4 papers) and Pneumonia and Respiratory Infections (3 papers). E.A.P. Croydon is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Drug-Induced Adverse Reactions (4 papers) and Pneumonia and Respiratory Infections (3 papers). E.A.P. Croydon collaborates with scholars based in Australia, Greece and United Kingdom. E.A.P. Croydon's co-authors include R. Sutherland, G. N. Rolinson, Elisa Knudsen, Rebecca Sutherland, Stephen W. Elson, J. W. Harding, Jeremy Grimshaw, Morton J. Cowan, A. Geddes and Jamie Murdoch and has published in prestigious journals such as The Lancet, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

E.A.P. Croydon

12 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.A.P. Croydon Australia 8 201 97 83 65 40 12 399
L. Magni Sweden 10 152 0.8× 72 0.7× 54 0.7× 69 1.1× 21 0.5× 21 304
L Mizen United Kingdom 12 149 0.7× 89 0.9× 59 0.7× 79 1.2× 36 0.9× 23 355
Gordon Brier United States 11 223 1.1× 108 1.1× 123 1.5× 112 1.7× 63 1.6× 19 400
R. D. Foord United States 9 305 1.5× 118 1.2× 39 0.5× 142 2.2× 35 0.9× 15 493
P. J. Wilkinson United Kingdom 10 143 0.7× 109 1.1× 99 1.2× 99 1.5× 41 1.0× 16 353
S. C. Schimpff United States 11 167 0.8× 131 1.4× 59 0.7× 124 1.9× 79 2.0× 18 498
Ronald A. Young United States 9 137 0.7× 93 1.0× 39 0.5× 41 0.6× 13 0.3× 13 377
A.P. Gillett United Kingdom 10 286 1.4× 109 1.1× 74 0.9× 156 2.4× 51 1.3× 22 463
J. D. Wolny United States 8 164 0.8× 103 1.1× 109 1.3× 90 1.4× 53 1.3× 11 341
James H. Paton United Kingdom 5 100 0.5× 66 0.7× 123 1.5× 49 0.8× 59 1.5× 6 309

Countries citing papers authored by E.A.P. Croydon

Since Specialization
Citations

This map shows the geographic impact of E.A.P. Croydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.A.P. Croydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.A.P. Croydon more than expected).

Fields of papers citing papers by E.A.P. Croydon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.A.P. Croydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.A.P. Croydon. The network helps show where E.A.P. Croydon may publish in the future.

Co-authorship network of co-authors of E.A.P. Croydon

This figure shows the co-authorship network connecting the top 25 collaborators of E.A.P. Croydon. A scholar is included among the top collaborators of E.A.P. Croydon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.A.P. Croydon. E.A.P. Croydon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Croydon, E.A.P.. (1986). General Discussion: Section 3. Drugs. 31(Supplement 3). 115–115. 4 indexed citations
3.
Croydon, E.A.P., et al.. (1986). An evaluation of the safety and tolerance of Timentin. Journal of Antimicrobial Chemotherapy. 17(suppl C). 233–240. 5 indexed citations
4.
Croydon, E.A.P., et al.. (1982). A Comparative Study of the Effectiveness and Safety of Two Non-Steroidal Anti-Inflammatory Agents, Nabumetone and Naproxen in Rheumatoid Arthritis. Journal of International Medical Research. 10(4). 204–208. 7 indexed citations
5.
Croydon, E.A.P., Jeremy Grimshaw, Morton J. Cowan, et al.. (1973). Prospective Study of Ampicillin Rash. BMJ. 1(5844). 7–9. 28 indexed citations
6.
Croydon, E.A.P., et al.. (1973). A winter-long trial of ampicillin in chronic bronchitis. British Journal of Diseases of the Chest. 67(2). 153–160. 10 indexed citations
7.
Croydon, E.A.P.. (1973). Clinical Experience of Amoxycillin in the United Kingdom. Chemotherapy. 18(1). 112–118. 1 indexed citations
8.
Sutherland, R., E.A.P. Croydon, & G. N. Rolinson. (1972). Amoxycillin: A new Semi-synthetic Penicillin. BMJ. 3(5817). 13–16. 138 indexed citations
9.
Sutherland, Rebecca, Stephen W. Elson, & E.A.P. Croydon. (1972). Metampicillin. Chemotherapy. 17(3). 145–160. 11 indexed citations
10.
Harding, J. W., et al.. (1970). Successful treatment of osteomyelitis caused by Pseudomonas aeruginosa. Journal of Clinical Pathology. 23(8). 653–656. 6 indexed citations
11.
Sutherland, R., E.A.P. Croydon, & G. N. Rolinson. (1970). Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin. BMJ. 4(5733). 455–460. 148 indexed citations
12.
Knudsen, Elisa, et al.. (1967). CUTANEOUS SENSITIVITY TO PURIFIED BENZYLPENICILLIN. The Lancet. 289(7501). 1184–1188. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Magni Breakdown of academic impact, for papers by L Mizen Breakdown of academic impact, for papers by Gordon Brier Breakdown of academic impact, for papers by R. D. Foord Breakdown of academic impact, for papers by P. J. Wilkinson Breakdown of academic impact, for papers by S. C. Schimpff Breakdown of academic impact, for papers by Ronald A. Young Breakdown of academic impact, for papers by A.P. Gillett Breakdown of academic impact, for papers by J. D. Wolny Breakdown of academic impact, for papers by James H. Paton
Rankless by CCL
2026